Related Experiment Video
Updated: Aug 16, 2026

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Prothrombotic status in COVID‑19 with diabetes mellitus (Review)
Roxana Madalina Mitroi1, Vlad Padureanu2, Adina Mitrea3,4
1Department of Diabetes, Nutrition and Metabolic Diseases, County Clinical Emergency Hospital of Craiova, 200642 Craiova, Romania.
Insights
Diabetes exacerbates COVID-19 severity by increasing inflammation and immune dysfunction. This elevates the risk of thrombotic events and worse outcomes in patients with coronavirus disease-19 (COVID-19).
Area of Science:
- Immunology
- Infectious Diseases
- Endocrinology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, causing coronavirus disease-19 (COVID-19), presents significant global health and economic challenges.
- COVID-19 pathogenesis involves complex host-virus immune interactions, leading to hyperinflammation, cytokine storms, and dysregulated coagulation and fibrinolysis.
- Diabetes mellitus is a known risk factor for severe COVID-19 complications, linked to chronic low-grade inflammation and immune response dysfunction.
Purpose of the Study:
- To investigate the role of diabetes in the severity and prognosis of COVID-19.
- To explore the mechanisms linking diabetes, immune dysfunction, and thrombotic events in COVID-19 patients.
Main Methods:
- Review of existing literature on COVID-19 pathogenesis, diabetes, and thrombotic complications.
- Analysis of immune response pathways and metabolic disturbances in diabetic patients.
- Correlation of diabetes status with COVID-19 severity and thrombotic event risk.
Main Results:
- Patients with diabetes exhibit impaired innate and adaptive immune responses.
- Metabolic disturbances in diabetes disrupt the balance between coagulation and fibrinolysis, increasing thrombotic risk.
- Diabetes is significantly associated with a prothrombotic state, contributing to worse COVID-19 prognosis.
Conclusions:
- Diabetes is a critical factor influencing COVID-19 severity, primarily through immune dysregulation and a prothrombotic state.
- The increased risk of thrombotic events in diabetic COVID-19 patients underscores the need for targeted management strategies.
- Understanding these interactions is crucial for improving outcomes in vulnerable diabetic populations affected by COVID-19.
Abstract:
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has caused an important social and health impact worldwide and the coronavirus disease-19 (COVID-19) has elicited devastating economy problems. The pathogenesis of SARS-CoV-2 infection is a complex mechanism and is considered to be the result of a challenging interaction, in which host and virus immune responses are the key elements. In this process, several inflammatory pathways are involved, and their initiation can have multiple consequences with a considerable impact on evolution, such as hyperinflammation and cytokine storm, thereby promoting activation of the coagulation system and fibrinolytic activity suppression. It is commonly recognized that COVID-19 severity involves multiple factors, including diabetes which increases the risk of developing different complications. This could be as a result of the low-grade inflammation as well as the innate and adaptive immune response dysfunction that is observed in patients with diabetes mellitus. In patients with diabetes, multiple metabolic disturbances which have a major impact in disturbing the balance between coagulation and fibrinolysis were discovered, thus the risk for thrombotic events is increased. Diabetes has been recognized as an important severity prognosis factor in COVID-19 cases and considering there is a significant association between diabetes and prothrombotic status, it could be responsible for the increased risk of thrombotic events with a worse prognosis.
More Related Videos
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Introduction
Type I Diabetes II: Pathophysiology
Type II Diabetes II: Pathophysiology
Complications of Diabetes Mellitus